RWE/RWD

 

 

Here we will focus on data curation and collection to drive forward new cures. Transferring Real World Data to Real World Evidence and the development of new cures. Curating data at scale is fraught with challenges on how to best go about this. We will explore how new partnership models are driving forward data porosity across the health system as a whole from payers, pharma, hospitals, regulators and central databanks. Learn about new integrated methods and what the future holds for this space.

THIS YEAR’S WORLD LEADING RWE/RWD SPEAKERS

 

 

 

RWE & RWD, Tuesday 2 November 2021

08:40

Opening Remarks

Trevor Howe
09:00

Looking at the bigger picture: How do we make sure that we have the full picture with big data experiments

Joachim Reischl
09:20

Deep Medicine – towards the next generation of software-based precision medicine diagnostics

  • Evolution of precision medicine
  • AI in predicting clinical outcome
  • Software as Medical Device as Companion Diagnostic
Panel discussion
09:40

Essential Tools for Accelerating Pipeline Productivity & Success

What tools are in your toolkit? Join this leading biopharma panel discussion to find out how to give your AI-based drug discovery and development program a competitive edge and increase program success.
10:40

Networking Break

Bernard Hamelin
RWE & RWD
11:40

The RWD & Advanced Analytics Revolution – The Transformation of Pharmaceuticals to Reduce Risk, Accelerate R&D & Develop Pipelines of The Future

RWE & RWD
12:00

Nashville Biosciences

Parker Moss
RWE & RWD
12:20

Genomics in Drug Development – Whole Genome Sequencing and Beyond

  • Genomics England and national scale whole genome sequencing
  • Target discovery and RWE and cancer research
  • Diagnostic discovery and the future of rare disease
RWE & RWD
12:40

IQVIA

Lana Denysyk
RWE & RWD
13:00

Building a RWD ecosystem to generate RWE

13:20

Networking Lunch Break

Heide Stirnadel Farrant
RWE & RWD
15:00

Building a network of RW data in rare eosinophilic diseases (EDs)

  • This network includes a variety of primary and secondary observational studies
  • To address knowledge gaps in the disease natural history of EDs including treatment patterns, HCRU and costs
  • Information is essential to understand disease burden, prognosis and progression to make informed decisions on long term medical interventions and therapies
Maria Del Pilar Schneider
RWE & RWD
15:20

What are the challenges associated to RWD/RWE in rare diseases?

  • How to assess whether RWD can support your business or medical questions?
  • Will RWD provide you the level of granularity you need?
  • What type of data we would like to have in the future?
RWE & RWD
15:40

Rhino Reserved

Mary Helen Black
RWE & RWD
16:00

Data sharing and partnerships across Janssen to develop new cures

16:20

Networking Break

RWE & RWD
17:00

Syapse Reserved

18:00

Neri & Sons Band & Networking Drinks Reception

last published: 27/Jul/21 14:25

RWE & RWD, Wednesday 3 November 2021

Steffen Roellinger
09:00

Decentralised Clinical Trials

  • Discussing the adoption of decentralised clinical trials at Bayer
  • New digital addoption
  • The Bayer trials transformaiton over COVID-19
Andrew Kasarskis
09:00

Digital transformation over COVID-19 – Challenges for the future and perpetuating the efforts

  • COVID-19 lead to digital innovation by necessity, including telehealth, new apps and digital technologies, and data fusion and sharing advances.
  • Large opportunities exist to do much better with learning from data, however.This requires the following operational and cultural change:
-Proactive collection and use of coherent data sets as a baseline for public health and the infrastructure development to support that work.-Recommitment to evidence-based medicine and timely, rigorous assessment of clinical utility through ongoing clinical research with well-powered studies of strong statistical design coupled to careful monitoring of large observational data.
Said Ismail
09:20

Qatar Genome; Big data from an underrepresented region

  • Overview of the Qatar Genome Project (QGP)
  • Contributions to Middle East Genomics
  • QGP role COVID-19 research
  • Strategy for precision medicine implementation
09:20

SevenBridges

Panel discussion
09:40

BC Platforms - Keynote Panel

Paul Agapow
09:40

How to be right: effective use of clinical models and machine learning in the clinic

    There is an increasing demand for a sophisticated model to predict patient outcomes and suggest treatmentsUnfortunately, most proposed clinical models are not fit for purpose, being biased, unvalidated, or irrelevantHere we suggest best practices for the development and deployment of complex ML algorithms, resulting in more successful and effective models
10:20

Networking Break + Speed Networking

RWE & RWD
11:40

LEAPYEAR

Alexander Sherman
RWE & RWD
12:20

How the lines between health system and pharma should be redrawn to allow patient data flow

13:00

Networking Lunch Break

RWE & RWD
14:40

Sponsor

RWE & RWD
15:20

Sponsor

Elise Bordet
RWE & RWD
15:40

Utilization of Real-World Evidence for Drug Development in Oncology

  • External control arm for oncology development
  • Modelling and prediction of non-adherence in breast cancer
  • Prediction of the best indication for a drug in oncology
16:00

Networking Break

Adrian Egli
RWE & RWD
16:40

Sepsis and Data Sharing: Developing an Architecture for AI Driven Digital Biomarker Development

18:00

Drinks Reception

last published: 27/Jul/21 14:25

RWE & RWD, Thursday 4 November 2021

Scott Chandler
09:00

Genetic Drivers of Response to Immunotherapy: Going Beyond the Tumor

09:20

GenomeSys

Thomas Hach
10:40

The Future of Precision Healthcare – Multi-Omics Humanized

  • Personalization of healthcare, not only of drug treatment, is the future
  • Patient influence, patient data and patient-desired outcomes are the most disruptive factors
  • How can we move from sterile biosignatures to a humanized approach?
RWE & RWD
14:00

Presentation

RWE & RWD
14:30

Sponsor

RWE & RWD
14:50

Presentation

RWE & RWD
15:10

Sponsor

RWE & RWD
15:30

Presentation

last published: 27/Jul/21 14:25

 

GET INVOLVED AT BIODATA WORLD CONGRESS

 

 

TO SPONSOR


Alistair Wilmot
alistair.wilmot@terrapinn.com
0207 092 1174

 

 

TO SPEAK


Edward Glanville

edward.glanville@terrapinn.com
0207 092 1042

 

 

MARKETING OPPORTUNITIES


Onika Akhtar
onika.akhtar@terrapinn.com
0207 092 1034